Loading…

Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents

The binding behaviour between calf thymus DNA and synthesized benzothiazolyl triazolium derivatives as potent antimicrobial agents was explored by means of spectroscopic applications together with molecular docking study at the sub-domain IIA, binding site I of human serum albumin (HSA). Most of the...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medicinal chemistry 2018-04, Vol.150, p.228-247
Main Authors: Maddili, Swetha K., Katla, Ramesh, Kannekanti, Vijaya Kumar, Bejjanki, Naveen Kumar, Tuniki, Balaraju, Zhou, Cheng-He, Gandham, Himabindu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3
cites cdi_FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3
container_end_page 247
container_issue
container_start_page 228
container_title European journal of medicinal chemistry
container_volume 150
creator Maddili, Swetha K.
Katla, Ramesh
Kannekanti, Vijaya Kumar
Bejjanki, Naveen Kumar
Tuniki, Balaraju
Zhou, Cheng-He
Gandham, Himabindu
description The binding behaviour between calf thymus DNA and synthesized benzothiazolyl triazolium derivatives as potent antimicrobial agents was explored by means of spectroscopic applications together with molecular docking study at the sub-domain IIA, binding site I of human serum albumin (HSA). Most of the synthesized derivatives presented significant antimicrobial inhibition when compared with the clinical Norfloxacin, Chloromycin, and Fluconazole. In particular, compound 5q presented efficient anti-Bacillus subtilis, anti-Escherichia coli, anti-Salmonella typhi, and anti-Psuedomonas aeruginosa activity with low MIC values of 2–8 μg/mL which were relatively superior to the reference drugs. The preliminarily investigation of interaction studies with calf thymus DNA demonstrated that the most active compound 5q could effectively intercalate into DNA to form 5q-DNA complex. Further investigations revealed that human serum albumin could effectively transport compound 5q while molecular modelling studies with good docking score showed that hydrophobic interactions as well as hydrogen bonds played a significant role in the interaction of compound 5q with HSA. In addition, the cytotoxic investigation carried out on four different cancerous cell lines (3 human cell lines and 1 murine cell lines) by MTT assay presented that compound 5n is active against MDA cell lines with IC50 values less than 100 μg/mL. [Display omitted] •Novel imidazo [2,1-b] benzothiazolyl triazolium analogues were synthesized and assessed for antimicrobial activity.•Interaction mode between calf thymus DNA and compound 5q was explored by spectroscopic techniques.•Good molecular docking score revealed the interaction of compound 5q with HSA at sub-domain IIA binding site.•Cytotoxic investigation was carried out on four different cancerous cell lines by MTT Assay.
doi_str_mv 10.1016/j.ejmech.2018.02.056
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2013519491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523418301934</els_id><sourcerecordid>2013519491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3</originalsourceid><addsrcrecordid>eNp9kcuOFCEUhonROO3oGxjD0k2V3Oq2MemMlzEZdaGuCVCHLjpU0QLVpuddfFeZ6dGlCQkEvv_8nPMj9JKSmhLavtnXsJ_BTDUjtK8Jq0nTPkIb2rV9xVkjHqMNYYxXDePiAj1LaU9IQQh5ii7Y0JRF2Ab9_hw8mNWriN2SISqTXVhwsHgJR_BYw3Ib8uTUbfAnj3O8P7l1xmpRPuxWSPiXyxM2ylucp9O8Jvzuy7Y8j_j627bKE7iItQsFdgUqNkdI2e3UvZFK-BAyLLkIspudiUG7QqlduUvP0ROrfIIXD_sl-vHh_fer6-rm68dPV9ubyvCW5WpQYuQdbQQ1thFMC2VBA2OMtEBp2_ZjB9B1bOgtNIYIbZRVjKtec0q1tfwSvT7XPcTws7SU5eySAe_VAmFNsoyYN3QQAy2oOKPlpylFsPIQ3aziSVIi74KRe3kO5k7VS8JkmXqRvXpwWPUM4z_R3yQK8PYMQOnz6CDKZBwsBkYXwWQ5Bvd_hz8ATKVf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2013519491</pqid></control><display><type>article</type><title>Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents</title><source>Elsevier</source><creator>Maddili, Swetha K. ; Katla, Ramesh ; Kannekanti, Vijaya Kumar ; Bejjanki, Naveen Kumar ; Tuniki, Balaraju ; Zhou, Cheng-He ; Gandham, Himabindu</creator><creatorcontrib>Maddili, Swetha K. ; Katla, Ramesh ; Kannekanti, Vijaya Kumar ; Bejjanki, Naveen Kumar ; Tuniki, Balaraju ; Zhou, Cheng-He ; Gandham, Himabindu</creatorcontrib><description>The binding behaviour between calf thymus DNA and synthesized benzothiazolyl triazolium derivatives as potent antimicrobial agents was explored by means of spectroscopic applications together with molecular docking study at the sub-domain IIA, binding site I of human serum albumin (HSA). Most of the synthesized derivatives presented significant antimicrobial inhibition when compared with the clinical Norfloxacin, Chloromycin, and Fluconazole. In particular, compound 5q presented efficient anti-Bacillus subtilis, anti-Escherichia coli, anti-Salmonella typhi, and anti-Psuedomonas aeruginosa activity with low MIC values of 2–8 μg/mL which were relatively superior to the reference drugs. The preliminarily investigation of interaction studies with calf thymus DNA demonstrated that the most active compound 5q could effectively intercalate into DNA to form 5q-DNA complex. Further investigations revealed that human serum albumin could effectively transport compound 5q while molecular modelling studies with good docking score showed that hydrophobic interactions as well as hydrogen bonds played a significant role in the interaction of compound 5q with HSA. In addition, the cytotoxic investigation carried out on four different cancerous cell lines (3 human cell lines and 1 murine cell lines) by MTT assay presented that compound 5n is active against MDA cell lines with IC50 values less than 100 μg/mL. [Display omitted] •Novel imidazo [2,1-b] benzothiazolyl triazolium analogues were synthesized and assessed for antimicrobial activity.•Interaction mode between calf thymus DNA and compound 5q was explored by spectroscopic techniques.•Good molecular docking score revealed the interaction of compound 5q with HSA at sub-domain IIA binding site.•Cytotoxic investigation was carried out on four different cancerous cell lines by MTT Assay.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2018.02.056</identifier><identifier>PMID: 29529502</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Antibacterial ; Calf thymus DNA ; Human serum albumin ; Imidazo [2,1-b] benzothiazole ; Molecular docking ; Triazole</subject><ispartof>European journal of medicinal chemistry, 2018-04, Vol.150, p.228-247</ispartof><rights>2018 Elsevier Masson SAS</rights><rights>Copyright © 2018 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3</citedby><cites>FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3</cites><orcidid>0000-0002-8071-178X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29529502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maddili, Swetha K.</creatorcontrib><creatorcontrib>Katla, Ramesh</creatorcontrib><creatorcontrib>Kannekanti, Vijaya Kumar</creatorcontrib><creatorcontrib>Bejjanki, Naveen Kumar</creatorcontrib><creatorcontrib>Tuniki, Balaraju</creatorcontrib><creatorcontrib>Zhou, Cheng-He</creatorcontrib><creatorcontrib>Gandham, Himabindu</creatorcontrib><title>Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>The binding behaviour between calf thymus DNA and synthesized benzothiazolyl triazolium derivatives as potent antimicrobial agents was explored by means of spectroscopic applications together with molecular docking study at the sub-domain IIA, binding site I of human serum albumin (HSA). Most of the synthesized derivatives presented significant antimicrobial inhibition when compared with the clinical Norfloxacin, Chloromycin, and Fluconazole. In particular, compound 5q presented efficient anti-Bacillus subtilis, anti-Escherichia coli, anti-Salmonella typhi, and anti-Psuedomonas aeruginosa activity with low MIC values of 2–8 μg/mL which were relatively superior to the reference drugs. The preliminarily investigation of interaction studies with calf thymus DNA demonstrated that the most active compound 5q could effectively intercalate into DNA to form 5q-DNA complex. Further investigations revealed that human serum albumin could effectively transport compound 5q while molecular modelling studies with good docking score showed that hydrophobic interactions as well as hydrogen bonds played a significant role in the interaction of compound 5q with HSA. In addition, the cytotoxic investigation carried out on four different cancerous cell lines (3 human cell lines and 1 murine cell lines) by MTT assay presented that compound 5n is active against MDA cell lines with IC50 values less than 100 μg/mL. [Display omitted] •Novel imidazo [2,1-b] benzothiazolyl triazolium analogues were synthesized and assessed for antimicrobial activity.•Interaction mode between calf thymus DNA and compound 5q was explored by spectroscopic techniques.•Good molecular docking score revealed the interaction of compound 5q with HSA at sub-domain IIA binding site.•Cytotoxic investigation was carried out on four different cancerous cell lines by MTT Assay.</description><subject>Antibacterial</subject><subject>Calf thymus DNA</subject><subject>Human serum albumin</subject><subject>Imidazo [2,1-b] benzothiazole</subject><subject>Molecular docking</subject><subject>Triazole</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kcuOFCEUhonROO3oGxjD0k2V3Oq2MemMlzEZdaGuCVCHLjpU0QLVpuddfFeZ6dGlCQkEvv_8nPMj9JKSmhLavtnXsJ_BTDUjtK8Jq0nTPkIb2rV9xVkjHqMNYYxXDePiAj1LaU9IQQh5ii7Y0JRF2Ab9_hw8mNWriN2SISqTXVhwsHgJR_BYw3Ib8uTUbfAnj3O8P7l1xmpRPuxWSPiXyxM2ylucp9O8Jvzuy7Y8j_j627bKE7iItQsFdgUqNkdI2e3UvZFK-BAyLLkIspudiUG7QqlduUvP0ROrfIIXD_sl-vHh_fer6-rm68dPV9ubyvCW5WpQYuQdbQQ1thFMC2VBA2OMtEBp2_ZjB9B1bOgtNIYIbZRVjKtec0q1tfwSvT7XPcTws7SU5eySAe_VAmFNsoyYN3QQAy2oOKPlpylFsPIQ3aziSVIi74KRe3kO5k7VS8JkmXqRvXpwWPUM4z_R3yQK8PYMQOnz6CDKZBwsBkYXwWQ5Bvd_hz8ATKVf</recordid><startdate>20180425</startdate><enddate>20180425</enddate><creator>Maddili, Swetha K.</creator><creator>Katla, Ramesh</creator><creator>Kannekanti, Vijaya Kumar</creator><creator>Bejjanki, Naveen Kumar</creator><creator>Tuniki, Balaraju</creator><creator>Zhou, Cheng-He</creator><creator>Gandham, Himabindu</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8071-178X</orcidid></search><sort><creationdate>20180425</creationdate><title>Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents</title><author>Maddili, Swetha K. ; Katla, Ramesh ; Kannekanti, Vijaya Kumar ; Bejjanki, Naveen Kumar ; Tuniki, Balaraju ; Zhou, Cheng-He ; Gandham, Himabindu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibacterial</topic><topic>Calf thymus DNA</topic><topic>Human serum albumin</topic><topic>Imidazo [2,1-b] benzothiazole</topic><topic>Molecular docking</topic><topic>Triazole</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maddili, Swetha K.</creatorcontrib><creatorcontrib>Katla, Ramesh</creatorcontrib><creatorcontrib>Kannekanti, Vijaya Kumar</creatorcontrib><creatorcontrib>Bejjanki, Naveen Kumar</creatorcontrib><creatorcontrib>Tuniki, Balaraju</creatorcontrib><creatorcontrib>Zhou, Cheng-He</creatorcontrib><creatorcontrib>Gandham, Himabindu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maddili, Swetha K.</au><au>Katla, Ramesh</au><au>Kannekanti, Vijaya Kumar</au><au>Bejjanki, Naveen Kumar</au><au>Tuniki, Balaraju</au><au>Zhou, Cheng-He</au><au>Gandham, Himabindu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2018-04-25</date><risdate>2018</risdate><volume>150</volume><spage>228</spage><epage>247</epage><pages>228-247</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>The binding behaviour between calf thymus DNA and synthesized benzothiazolyl triazolium derivatives as potent antimicrobial agents was explored by means of spectroscopic applications together with molecular docking study at the sub-domain IIA, binding site I of human serum albumin (HSA). Most of the synthesized derivatives presented significant antimicrobial inhibition when compared with the clinical Norfloxacin, Chloromycin, and Fluconazole. In particular, compound 5q presented efficient anti-Bacillus subtilis, anti-Escherichia coli, anti-Salmonella typhi, and anti-Psuedomonas aeruginosa activity with low MIC values of 2–8 μg/mL which were relatively superior to the reference drugs. The preliminarily investigation of interaction studies with calf thymus DNA demonstrated that the most active compound 5q could effectively intercalate into DNA to form 5q-DNA complex. Further investigations revealed that human serum albumin could effectively transport compound 5q while molecular modelling studies with good docking score showed that hydrophobic interactions as well as hydrogen bonds played a significant role in the interaction of compound 5q with HSA. In addition, the cytotoxic investigation carried out on four different cancerous cell lines (3 human cell lines and 1 murine cell lines) by MTT assay presented that compound 5n is active against MDA cell lines with IC50 values less than 100 μg/mL. [Display omitted] •Novel imidazo [2,1-b] benzothiazolyl triazolium analogues were synthesized and assessed for antimicrobial activity.•Interaction mode between calf thymus DNA and compound 5q was explored by spectroscopic techniques.•Good molecular docking score revealed the interaction of compound 5q with HSA at sub-domain IIA binding site.•Cytotoxic investigation was carried out on four different cancerous cell lines by MTT Assay.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29529502</pmid><doi>10.1016/j.ejmech.2018.02.056</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0002-8071-178X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2018-04, Vol.150, p.228-247
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_2013519491
source Elsevier
subjects Antibacterial
Calf thymus DNA
Human serum albumin
Imidazo [2,1-b] benzothiazole
Molecular docking
Triazole
title Molecular interaction of novel benzothiazolyl triazolium analogues with calf thymus DNA and HSA-their biological investigation as potent antimicrobial agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A23%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20interaction%20of%20novel%20benzothiazolyl%20triazolium%20analogues%20with%20calf%20thymus%20DNA%20and%20HSA-their%20biological%20investigation%20as%20potent%20antimicrobial%20agents&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Maddili,%20Swetha%20K.&rft.date=2018-04-25&rft.volume=150&rft.spage=228&rft.epage=247&rft.pages=228-247&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2018.02.056&rft_dat=%3Cproquest_cross%3E2013519491%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-9a4d371541cf542b4afebe22206e11668d7ee77298fe5c04bcafa23a8b311bff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2013519491&rft_id=info:pmid/29529502&rfr_iscdi=true